Rutao Li
Overview
Explore the profile of Rutao Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pan Z, Qian Y, Wang Y, Zhang T, Song X, Ding H, et al.
Cancer Sci
. 2025 Feb;
PMID: 39939568
KRAS inhibitors exhibit conspicuous clinical response in KRAS-mutant lung cancer, yet adaptive resistance, the rapid onset of intrinsic resistance, dampens their therapeutic success. Rational combination strategies could tackle this challenging...
2.
Song X, Pan Z, Zhang Y, Yang W, Zhang T, Wang H, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2403851.
PMID: 39899538
Current understanding of micropapillary (MP)-subtype lung adenocarcinoma (LUAD) remains confined to biological activities and genomic landscapes. Unraveling the major regulatory programs underlying MP patterned malignancy offers opportunities to identify more...
3.
Ding H, Xia W, Zhou Y, Wei L, Feng Y, Wang Z, et al.
NPJ Digit Med
. 2025 Feb;
8(1):77.
PMID: 39894840
This study investigates the application of prompt engineering to optimize prompt-driven ChatGPT for generating electronic medical records (EMRs) during lung nodule screening. We assessed the performance of ChatGPT in generating...
4.
Li R, Li N, Yang Q, Tong X, Wang W, Li C, et al.
Genome Med
. 2024 Dec;
16(1):148.
PMID: 39696540
Background: Understanding the stepwise progression of esophageal squamous cell carcinoma (ESCC) is crucial for developing customized strategies for early detection and optimal clinical management. Herein, we aimed to unravel the...
5.
Zhang Y, Song X, Feng Y, Qian Y, Chen B, Zhang T, et al.
Cancer Res
. 2024 Nov;
85(3):497-514.
PMID: 39531509
Immunogenic cell death (ICD) induces an active immune response. Activating ICD represents a potential approach to boost the antitumor activity of immunotherapy, highlighting the need to identify effective and safe...
6.
Wang Q, Song X, Zhang Y, Liang S, Zhang M, Wang H, et al.
Cell Rep
. 2024 Jul;
43(8):114550.
PMID: 39058593
Despite being the leading cause of lung cancer-related deaths, the underlying molecular mechanisms driving metastasis progression are still not fully understood. Transfer RNA-derived fragments (tRFs) have been implicated in various...
7.
Li R, Zhang Y, Wang A, Feng Y, Zhang T, Wang H, et al.
Cell Death Discov
. 2024 Jul;
10(1):334.
PMID: 39043648
Previous studies revealed that MIR155HG possessed an oncogenic role in many types of tumors including lung adenocarcinoma (LUAD), along with higher expression in tumors. However, in our study, we observed...
8.
Wang H, Hu Q, Chen Y, Huang X, Feng Y, Shi Y, et al.
Nat Commun
. 2024 May;
15(1):4195.
PMID: 38760351
Osimertinib (Osi) is a widely used epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). However, the emergence of resistance is inevitable, partly due to the gradual evolution of adaptive resistant...
9.
Wen S, Zou R, Du X, Pan R, Li R, Xia J, et al.
Heliyon
. 2024 Mar;
10(6):e27170.
PMID: 38500993
Background: Malignant tumours, particularly non-small cell lung cancer (NSCLC), pose a significant threat to human health due to their prevalence and lethality. Treatment methods for NSCLC vary greatly among individuals,...
10.
Huang H, Li N, Liang Y, Li R, Tong X, Xiao J, et al.
Clin Transl Med
. 2023 Nov;
13(11):e1493.
PMID: 38009315
Background: Biopsies obtained from primary oesophageal squamous cell carcinoma (ESCC) guide diagnosis and treatment. However, spatial intra-tumoral heterogeneity (ITH) influences biopsy-derived information and patient responsiveness to therapy. Here, we aimed...